Phase 1/2 Study of Biweekly ALIMTA Plus Cisplatin in Patients With Locally, Advanced, Non-Resectable or Metastatic Urothelial Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Cisplatin; Pemetrexed
- Indications Urogenital cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 23 Jun 2009 Actual number of patients changed from 54 to 59 as reported by ClinicalTrials.gov.
- 24 Mar 2009 Primary outcome amended as reported by ClinicalTrials.gov.
- 25 Jun 2008 The expected completion date for this trial is now 1 Dec 2009.